Table 3 Changes in cardiovascular disease risk factors of females following intensive lifestyle intervention
| Â | High-FMI | Low-FMI | High-FMI vs Low-FMI, p-value | High-ASMI vs Low-ASMI, p-value | FMI by ASMI interaction, p-value | ||
|---|---|---|---|---|---|---|---|
|  | High-ASMI (n = 157) | Low-ASMI (n = 272) | High-ASMI (n = 272) | Low-ASMI (n = 156) | |||
Body mass, kg | − 9.2 (6.7) | − 9.9 (6.0) | − 6.7 (5.8) | − 6.1 (4.7) |  < 0.001 | 0.698 | 0.304 |
BMI, kg/m2 | − 3.4 (2.5) | − 4.0 (2.4) | − 2.6 (1.1) | − 2.6 (2.0) |  < 0.001 | 0.609 | 0.203 |
A1C, mmol/mol | − 27.4 (10.3) | − 30.5 (10.8) | − 29.5 (10.7) | − 32.5 (12.6) | 0.275 | 0.097 | 0.937 |
A1C, % | − 0.36 (0.9) | − 0.65 (1.0) | − 0.55 (1.0) | − 0.82 (1.2) | 0.275 | 0.097 | 0.937 |
Fasting blood glucose, mg/dL | − 14.9 (45.3) | − 31.0 (49.8) | − 24.5 (33.8) | − 26.7 (55.3) | 0.622 | 0.669 | 0.165 |
HDL-C, mg/dL | 3.6 (7.9) | 2.5 (6.9) | 4.4 (8.5) | 4.0 (6.9) | 0.472 | 0.137 | 0.761 |
LDL-C, mg/dL | − 5.9 (31.1) | − 3.3 (29.5) | − 1.7 (25.3) | − 2.3 (37.4) | 0.896 | 0.594 | 0.467 |
Triglycerides, mg/dL | − 30.6 (143.9) | − 22.8 (85.2) | − 27.5 (76.2) | − 26.7 (97.0) | 0.828 | 0.659 | 0.441 |
Systolic blood pressure, mmHg | − 9 (19) | − 11 (18) | − 5 (17) | − 7 (15) | 0.183 | 0.045 | 0.907 |
Diastolic blood pressure, mmHg | − 3 (9) | − 4 (9) | − 2 (8) | − 2 (8) | 0.448 | 0.251 | 0.321 |
Cardiorespiratory fitness, MET | 1.6 (1.8) | 1.4 (1.8) | 1.8 (2.5) | 1.4 (2.5) | 0.755 | 0.264 | 0.596 |
Depression, point | − 3.1 (5.1) | − 2.6 (5.4) | − 1.4 (5.1) | − 1.4 (4.4) | 0.027 | 0.576 | 0.638 |
HR-QoL (PCS), point | 3.1 (7.0) | 2.5 (9.7) | 0.7 (6.8) | 3.2 (7.5) | 0.770 | 0.977 | 0.050 |
HR-QoL (MCS), point | 0.6 (10.4) | 1.2 (10.6) | 1.4 (10.0) | 1.2 (7.4) | 0.793 | 0.526 | 0.772 |